Armata Pharmaceuticals, Inc. (ARMP) has 6 open-market insider trades by 2 insiders since 2020. The most active filer is Innoviva, Inc., Director & 10% Owner.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Innoviva, Inc. | Dir10% Owner | — | 3 | $99.1M | 2022-03-31 |
| Innoviva Strategic Opportunities LLC | Dir10% Owner | — | 3 | $32.1M | 2023-01-10 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Innoviva, Inc. | Director & 10% Owner | Buy | $26.9M | 2022-03-31 |
| Innoviva Strategic Opportunities LLC | Director & 10% Owner | Buy | $18.1M | 2022-02-09 |
| Innoviva Strategic Opportunities LLC | Director & 10% Owner | Buy | $8.0M | 2021-10-29 |
| Innoviva, Inc. | Director & 10% Owner | Buy | $27.9M | 2021-03-17 |
| Innoviva Strategic Opportunities LLC | Director & 10% Owner | Buy | $6.1M | 2021-01-26 |
| Innoviva, Inc. | 10% Owner | Buy |
Companies that share insiders with ARMP, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| $44.3M |
| 2020-03-27 |